ClinicalTrials.gov
public full text
Public Domain
Eflornithine to Prevent Skin Cancer in Patients With Previously Treated Early Stage Skin Cancer
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of eflornithine may be an effective way to prevent the recurrence of or further development of skin cancer. PURPOSE: Randomized phase III trial to determine the effectiveness of eflornithine in preventing skin cancer in patients who have previously received treatment for early stage skin cancer.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Electrochemotherapy For The Treatment Of Breast Cancer That Has Spread to the Skin#1094754
- Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients#1086612
- Reasons for Indoor and Outdoor Tanning: Starting Points for Skin Cancer Prevention Based on a Nationwide Study.#232230
- Clinical and Biological Anti-aging Efficacy of a Cosmetic Cream#1102914
- Skin Cancer Prevention With Nicotinamide in Transplant Recipients - Pilot Trial#833679
Record · ID 899203
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive